Rapid and cost-effective cancer diagnostic and treatment identification
The Problem
In 2020, nearly 10 millions people dying from cancer
By 2040 cancer deaths are estimated to reach 16.4 million – representing a 71% increase
Cancer is a leading cause of death worldwide – 1 in 6 deaths is caused by cancer
Current Workflow
![](https://om-lot.tech/wp-content/uploads/2021/09/surgery.png)
Invasive
Complex and surgical process of tissue biopsy
![](https://om-lot.tech/wp-content/uploads/2021/09/microscope.png)
Imaging to diagnosis
Highly technical and lengthy steps to know if the patient has cancer or not
![](https://om-lot.tech/wp-content/uploads/2021/09/chemical-analysis.png)
Molecular analysis
Various, time-consuming steps to analyze the patient sample
Our Solution
![](https://om-lot.tech/wp-content/uploads/2021/07/bloof.png)
Fast
Using optical spectroscopy, we can shorten the diagnosis and screening process to less than a day
![](https://om-lot.tech/wp-content/uploads/2021/07/money.png)
Non-invasive
OM-LoT’s mission is to replace the highly invasive tissue biopsy by a simple blood draw
![](https://om-lot.tech/wp-content/uploads/2021/07/chrono.png)
Affordable
Our miniaturized technology has low equipment cost and provides diagnosis significantly cheaper than comparable tech
Bringing light into darkness
![](https://om-lot.tech/wp-content/uploads/2021/07/test.png)
Liquid Biopsy
Instead of a tissue biopsy, a blood sample is taken from the patient, circulating tumor cells are then isolated and ready for analysis
![](https://om-lot.tech/wp-content/uploads/2021/09/healthcare-device.png)
Optical Spectroscopy
Thanks to our innovative technology, circulating tumor cells are then analyzed in 2 hours and the results are sent directly to our algorithm
![](https://om-lot.tech/wp-content/uploads/2021/07/Picture14-e1626961785729.png)
Artificial Intelligence
Using artificial intelligence, we identify the most effective therapy based on the tumor type and deliver a personalized report to the patient
About the company
OM-LoT’s great value lies within empowering people to perform more frequent health check-ups, by a non-invasive, cost-effective, and quicker cancer diagnosis through liquid biopsy. This allows us to detect cancer earlier and act against it sooner in a more efficient manner. Together, we can increase the survival probability of cancer patients and save the lives of our loved ones.
![](https://om-lot.tech/wp-content/uploads/2021/07/medical-health-doctor.jpg)
OM-LoT in the news
SIBB DeepTech Startup Stipendien 2021: OM-LoT macht das Rennen
Die Entscheidung über das SIBB DeepTech Startup Stipendium 2021 ist gefallen: Die Gewinnerin heißt OM-LoT....
Read MoreSIBB DeepTech Startup Stipendium
OM-LoT got accepted to SIBB program, with almost 50% of votes from the jury
Read MoreOpTecBB Photonik Start-up graduate seminar
Dr Asa Asadollahbaik won the best pitch award in OptecBB entrepreneurship graduate program.
Read More![](https://om-lot.tech/wp-content/uploads/2021/08/Jochen.png)
Dr Jochen Fick
Collaborator/Advisor on Optical Fiber Optical Tweezers Senior Scientist CNRS Grenoble, France
Our Sponsors
![](https://om-lot.tech/wp-content/uploads/2021/05/esf_logo.jpg)
![](https://om-lot.tech/wp-content/uploads/2021/05/eu-sozialfonds.jpg)
![](https://om-lot.tech/wp-content/uploads/2021/05/B_SEN_WiEnBe_Logo_DE_V_PT_RGB-1024x683.png)
![](https://om-lot.tech/wp-content/uploads/2021/05/sibb_stipendium-1024x740.png)